Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
E-pub ahead of print

Elevated Expression of SLC6A4 Encoding the Serotonin Transporter (SERT) in Gilles de la Tourette Syndrome

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Stable Longitudinal Methylation Levels at the CpG Sites Flanking the CTG Repeat of DMPK in Patients with Myotonic Dystrophy Type 1

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. An Expanded Multi-Organ Disease Phenotype Associated with Mutations in YARS

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Hypermethylation of the VTRNA1-3 Promoter is Associated with Poor Outcome in Lower Risk Myelodysplastic Syndrome Patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Crosstalk between BH4, pain, and dystonia

    Research output: Contribution to journalComment/debateResearchpeer-review

  2. Clinical and molecular delineation of PUS3-associated neurodevelopmental disorders

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. ZMYND11 variants are a novel cause of centrotemporal and generalised epilepsies with neurodevelopmental disorder

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Identifying dominant-negative actions of a dopamine transporter variant in patients with parkinsonism and neuropsychiatric disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Classification of MSH6 Variants of Uncertain Significance Using Functional Assays

    Research output: Contribution to journalReviewResearchpeer-review

View graph of relations

Gilles de la Tourette syndrome (GTS) is a complex neurodevelopmental disorder characterized by motor and vocal tics. Most of the GTS individuals have comorbid diagnoses, of which obsessive-compulsive disorder (OCD) and attention deficit-hyperactivity disorder (ADHD) are the most common. Several neurotransmitter systems have been implicated in disease pathogenesis, and amongst these, the dopaminergic and the serotonergic pathways are the most widely studied. In this study, we aimed to investigate whether the serotonin transporter (SERT) gene (SLC6A4) was differentially expressed among GTS individuals compared to healthy controls, and whether DNA variants (the SERT-linked polymorphic region 5-HTTLPR, together with the associated rs25531 and rs25532 variants, and the rare Ile425Val variant) or promoter methylation of SLC6A4 were associated with gene expression levels or with the presence of OCD as comorbidity. We observed that SLC6A4 expression is upregulated in GTS individuals compared to controls. Although no specific genotype, allele or haplotype was overrepresented in GTS individuals compared to controls, we observed that the LAC/LAC genotype of the 5-HTTLPR/rs25531/rs25532 three-locus haplotype was associated with higher SLC6A4 mRNA expression levels in GTS individuals, but not in the control group.

Original languageEnglish
Article number86
JournalGenes
Volume12
Issue number1
Pages (from-to)1-10
Number of pages10
ISSN2073-4425
DOIs
Publication statusE-pub ahead of print - 12 Jan 2021

    Research areas

  • 5-HTT, Expression, Gilles de la Tourette syndrome, GTS, Methylation, Obsessive compulsive disorder, OCD, Serotonin, SERT, SLC6A4, expression, obsessive compulsive disorder, serotonin, methylation

ID: 62034576